ANGPTL3 is exclusively expressed in the human and mouse liver, and ANGPTL3 deletion in mice leads to increased post-heparin plasma LPL and endothelial lipase activity, reduced levels of circulating TGs and LDL, and reduced atherosclerosis (37–40). This evidence concerns the gene ANGPTL3 and atherosclerosis.